Antares Pharma, Inc.
(NASDAQ CM: ATRS)
Rigrodsky Law, P.A. is investigating Antares Pharma, Inc. (“Antares”) regarding possible breaches of fiduciary duties and other violations of law related to Antares’ agreement to be acquired by Halozyme Therapeutics, Inc. Under the terms of the agreement, Antares’ shareholders will receive $5.60 in cash for each share of Antares common stock they own.